These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3625096)

  • 21. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
    Sadoul JL; Thyss A; Freychet P
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):179-83. PubMed ID: 1543025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of dopamine in the pathogenesis of experimental prolactinomas.
    el-Azouzi M; Hsu DW; Black PM; Jolesz F; Hedley-Whyte ET; Klibanski A; Zervas NT
    J Neurosurg; 1990 Feb; 72(2):273-81. PubMed ID: 1967303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin messenger ribonucleic acid concentrations in 4-day cycling rats and during the prolactin surge.
    Haisenleder DJ; Ortolano GA; Landefeld TD; Zmeili SM; Marshall JC
    Endocrinology; 1989 Apr; 124(4):2023-8. PubMed ID: 2924734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat anterior pituitary neuropeptides following chronic prolactin manipulation: a combined radioimmunoassay and mRNA study.
    O'Halloran DJ; Jones PM; Ghatei MA; Bloom SR
    J Endocrinol; 1991 Dec; 131(3):411-9. PubMed ID: 1723745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kallikrein gene expression in estrogen-induced pituitary tumors.
    Fuller PJ; Matheson BA; MacDonald RJ; Verity K; Clements JA
    Mol Cell Endocrinol; 1988 Dec; 60(2-3):225-32. PubMed ID: 3215391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary. Experimental models for the human prolactinomas and the effects of bromocriptine.
    Osamura RY; Watanabe K
    Acta Pathol Jpn; 1986 Aug; 36(8):1131-7. PubMed ID: 3776530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anatomical and functional effects of estrogen-induced prolactinomas on the rat hypothalamus.
    Azad N; Nayyar R; Tentler J; Cernius M; Emanuele NV; Kirsteins L; Lawrence AM
    J Exp Pathol; 1989; 4(4):237-49. PubMed ID: 2614531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report.
    Clayton RN; Webb J; Heath DA; Dunn PJ; Rolfe EB; Hockley AD
    Clin Endocrinol (Oxf); 1985 May; 22(5):573-81. PubMed ID: 4028456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine agonist- and antagonist-induced modulation of pituitary gonadotrophin releasing hormone receptors are independent of changes in serum prolactin.
    Clayton RN; Bailey LC
    J Endocrinol; 1984 Aug; 102(2):215-23. PubMed ID: 6086802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of diethylstilbestrol and N-nitrosobutylurea-induced mammary and pituitary tumorigenesis in rats by prolonged treatment with 2-bromoergocryptine.
    Sumi C; Yokoro K; Matsushima R
    Cancer Res; 1983 Oct; 43(10):4781-5. PubMed ID: 6883334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of bromocriptine on prolactin-secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis.
    Mori H; Mori S; Saitoh Y; Arita N; Aono T; Uozumi T; Mogami H; Matsumoto K
    Cancer; 1985 Jul; 56(2):230-8. PubMed ID: 4005795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the ultrastructural distribution of prolactin and growth hormone mRNAs in pituitary cells of female rats after estrogen and bromocriptine treatment, studied using in situ hybridization with biotinylated oligonucleotide probes.
    Matsuno A; Ohsugi Y; Utsunomiya H; Takekoshi S; Sanno N; Osamura RY; Watanabe K; Teramoto A; Kirino T
    Histochem Cell Biol; 1995 Jul; 104(1):37-45. PubMed ID: 7584558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism by progesterone of diethylstilbestrol-induced pituitary tumorigenesis in Fischer 344 rats: effects on sex steroid receptors and tyrosine hydroxylase mRNA.
    Piroli GG; Grillo CA; Ferrini MG; Lux-Lantos V; De Nicola AF
    Neuroendocrinology; 1996 Jun; 63(6):530-9. PubMed ID: 8793895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
    Breidahl HD; Topliss DJ; Pike JW
    Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous sparsely-granulated prolactin-producing pituitary adenomas in aging rats. A prospective study of the effect of bromocriptine.
    McComb DJ; Hellmann P; Kovacs K; Scott D; Evans WS; Burdman JA; Thorner MO
    Neuroendocrinology; 1985 Sep; 41(3):201-11. PubMed ID: 4047338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal and morphologic effects of bromocriptine on normal rat pituitary and GH3 tumor cells.
    Lahteenmaki P; Marrs RP; Schechter J; Zacharias S; Kletzky OA
    Am J Obstet Gynecol; 1985 Oct; 153(4):349-57. PubMed ID: 4050909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: special reference to changes in secretory granules by stereological analysis].
    Saitoh Y; Koizumi K; Arita N; Hayakawa T; Aono T; Matsumoto K; Mogami H; Mori H
    No To Shinkei; 1987 Apr; 39(4):347-54. PubMed ID: 3593602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of prolactin messenger RNA in rat anterior pituitary by in situ hybridization.
    Lloyd RV; Landefeld TD
    Am J Pathol; 1986 Oct; 125(1):35-44. PubMed ID: 3777138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration by bromocriptine of glucocorticoid receptors and glucocorticoid negative feedback on prolactin secretion in estrogen-induced pituitary tumors.
    Piroli G; Grillo C; Ferrini M; Diaz-Torga G; Libertun C; De Nicola AF
    Neuroendocrinology; 1993 Sep; 58(3):273-9. PubMed ID: 8255389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical, electron microscopic, and morphometric studies of human prolactinomas after short-term bromocriptine treatment.
    Niwa J; Minase T; Mori M; Hashi K
    Surg Neurol; 1987 Nov; 28(5):339-44. PubMed ID: 3660204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.